Baxter
BAX
#1121
Rank
S$22.92 B
Marketcap
$44.91
Share price
0.98%
Change (1 day)
-13.36%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - Total debt

Total debt on the balance sheet as of September 2024 : S$17.90 Billion

According to Baxter's latest financial reports the company's total debt is S$17.90 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Baxter - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31S$18.97 B-17.74%
2022-12-31S$23.06 B-6.83%
2021-12-31S$24.75 B175%
2020-12-31S$9.00 B12.01%
2019-12-31S$8.03 B68.8%
2018-12-31S$4.76 B1.36%
2017-12-31S$4.69 B16.66%
2016-12-31S$4.02 B-56.26%
2015-12-31S$9.20 B-22.85%
2014-12-31S$11.93 B2.73%
2013-12-31S$11.61 B60.14%
2012-12-31S$7.25 B7.79%
2011-12-31S$6.72 B19.06%
2010-12-31S$5.65 B-3.03%
2009-12-31S$5.82 B8.49%
2008-12-31S$5.37 B20.84%
2007-12-31S$4.44 B3.49%
2006-12-31S$4.29 B-22.72%
2005-12-31S$5.55 B-20.66%
2004-12-31S$7.00 B-9.86%
2003-12-31S$7.77 B-3.62%
2002-12-31S$8.06 B62.1%
2001-12-31S$4.97 B21.61%
2000-12-31S$4.09 B-13.98%
1999-12-31S$4.75 B-14.46%
1998-12-31S$5.55 B18.64%
1997-12-31S$4.68 B64.03%
1996-12-31S$2.85 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
S$7.00 B-60.86%๐Ÿ‡บ๐Ÿ‡ธ USA
S$21.00 B 17.36%๐Ÿ‡บ๐Ÿ‡ธ USA
S$15.27 B-14.67%๐Ÿ‡บ๐Ÿ‡ธ USA
S$27.28 B 52.42%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.04 B-88.60%๐Ÿ‡บ๐Ÿ‡ธ USA
S$47.90 B 167.64%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.94 B-83.53%๐Ÿ‡บ๐Ÿ‡ธ USA
S$38.42 B 114.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$2.25 B-87.43%๐Ÿ‡บ๐Ÿ‡ธ USA